Director/PDMR Shareholding

Summary by AI BETAClose X

Savills PLC announced that David Lipson, Chief Executive Officer of Savills North America and a Person Discharging Managerial Responsibilities (PDMR), received 37,974 ordinary shares on 19 June 2026 under the Company's Deferred Share Plan, with the awards becoming unconditional. Following this transfer, Mr. Lipson's shareholding is 213,734 shares, representing 0.15% of the issued share capital. This transaction occurred outside a trading venue and involved no cost to Mr. Lipson.

Disclaimer*

Savills PLC
19 June 2026
 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)

 

Vesting of Share Awards

 

Awards over ordinary shares of the Company under the Deferred Share Plan have become unconditional in all respects following the end of their Deferred Period.  In satisfaction of the Awards, the Trustee of the Savills US Employee Benefit Trust effected the transfer of shares to a PDMR of the Company based in North America on 19 June 2026 as follows:-

 

 

PDMR

Number of Shares Transferred

Shareholding following this notification

Shareholding as a % of issued share capital

David Lipson

37,974

213,734

0.15%

 

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the Director/ PDMR

 

(a)

Name

David Lipson

 

2.

Reason for the notification

 

(a)

Position/ status

Chief Executive Officer - Savills North America/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Vesting of awards under the Company's Deferred Share Plan

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

 

37,974

(e)

Aggregated information

 

-      Aggregated volume

-      Price

 

N/A

 

 

(f)

Date of the transaction

 

19 June 2026

(g)

Place of the transaction

 

Outside a trading venue

 

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

19 June 2026      

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Savills (SVS)
UK 100

Latest directors dealings